If you are considering intrathecal pain pump targeted drug delivery for chronic pain, the biggest reality check is this: in a single-center survey of 443 patients with implanted pumps for non-cancer pain, complete discontinuation of oral opioid intake was self-reported by 38.9%.1 That is a satisfaction survey from one practice rather than a controlled trial, so read it as what those patients reported, not as an expected rate. That does not mean the pump is right for everyone, but it does explain why patients and clinicians keep coming back to this option when the assembly line keeps failing.
What causes the chronic pain pattern that a pump might help
Chronic pain involves motor control, muscle endurance, and central sensitization, not just one structural lesion. The pain you feel can keep signaling even after the original tissue injury stabilizes, because the nervous system learns the pattern and then maintains it.
That is where the pump can fit, especially when pain is refractory to standard stepwise care and symptoms suggest spinal cord level amplification. People who have mixed nociceptive and neuropathic features, refractory post-surgical pain, or complex regional pain features sometimes ask about intrathecal pain pump targeted drug delivery for chronic pain after multiple targeted procedures fail to provide durable control.
If the pain story is unclear, or if your symptoms are primarily driven by uncontrolled metabolic drivers and deconditioning, a pump can become a expensive detour. In 2026, we still see the same failure mode, the assembly line treats pain as a checklist instead of
How we diagnose pump candidacy, and why the diagnosis matters more than the imaging
We diagnose the pain problem you actually have, not the MRI report you already received. The most common clinical trap is assuming “images are normal, therefore the injury healed” means pain should also stop. The images are normal, therefore the injury healed, therefore what remains is stress, litigation, or catastrophizing.
Our evaluation typically includes:
- Pain phenotype (nociceptive, neuropathic, mixed), and where concordant pain is generated.
- Functional impact, sleep, mood, activity tolerance, and the realistic daily problem you want solved.
- Response history to interventional pain management options like nerve block pathways, epidural steroid injection approaches, radiofrequency ablation, and spinal cord stimulator screening when relevant.
- Central sensitization clues, because those often predict why “single lesion fixes” disappoint.
- Safety and risk assessment, including infection risk, bleeding risk, medication interactions, and device-related limitations.
If you are already exploring neuromodulation beyond pumps, we also coordinate conversations that overlap with interventional pain treatment options, and we make sure the plan is coherent rather than a bundle of unrelated procedures.
When an intrathecal pain pump is compared to other spinal and interventional options
Patients often compare pump therapy to spinal cord stimulator approaches, nerve blocks, ablation, and steroid injections. They are not the same, and in 2026 we are less interested in “which is newest” and more interested in whether your pain phenotype matches the mechanism.
Interventional steps that may come before (or alongside) a pump
- Nerve block strategies for diagnosis and short-term control, including targeted nerve block pathways.
- Facet joint injection or other image-guided injection approaches for specific pain generators, relevant to facet joint injection care.
- Epidural steroid injection approaches for inflammatory radicular patterns or other responsive syndromes.
- Radiofrequency ablation for longer-duration relief when pain generators show appropriate candidacy.
- Spinal cord stimulator discussions when the pattern looks more like dorsal column processing than medication effect is expected to dominate.
If you are debating a pump for a condition already discussed on our site, we will link rather than re-explain. For example, if you have pain that overlaps with known peripheral or central syndromes, check our targeted resources. For appointments and a coherent plan, use our locations and then contact us if you need help coordinating records.
Frequently asked questions
Is an intrathecal pain pump worth it for chronic pain?
It can be worth considering in 2026 for intrathecal pain pump targeted drug delivery for chronic pain when you have refractory symptoms, a credible spinal pain-processing component, and a plan for programming and follow-up. If your pain diagnosis is unclear or the main driver is metabolic pain management and deconditioning without a full rehab plan, the pump is less defensible. See spinal cord stimulation for how this is evaluated.
How does intrathecal targeted drug delivery differ from epidural steroid injection treatments?
Epidural steroid injection approaches deliver medication into tissues near the epidural space for specific targets and are typically short to medium duration. Intrathecal pain pump targeted drug delivery for chronic pain delivers medication directly into the intrathecal space for ongoing spinal effect, which changes both expected timelines and risk-benefit logic. See peripheral nerve stimulation for how this is evaluated.
What side effects should I expect with a spinal cord pump or intrathecal pump?
Side effects depend on the medication used and your dose response, but commonly include issues related to medication effects and device programming. A key practical point, the pump requires careful monitoring and dose adjustments to avoid tolerability problems. See cancer pain management for how this is evaluated.
Can intrathecal pain pump therapy help with CRPS treatment or reflex sympathetic dystrophy treatment?
Some patients with complex regional pain features discuss intrathecal pain pump targeted drug delivery for chronic pain when other targeted strategies fail, but outcomes are not identical across all pain phenotypes. We still evaluate CRPS using a circuit-based approach, and when ketamine for RSD is considered, it is part of a broader plan rather than an interchangeable substitute. See ketamine therapy for how this is evaluated.
Will a pump replace other interventional procedures like radiofrequency ablation or nerve block?
Not necessarily. Many people need a combined plan, where radiofrequency ablation or nerve block procedures address specific peripheral or segmental generators, while the pump targets ongoing spinal processing. See failed back surgery syndrome for how this is evaluated.
To discuss your own case, request an appointment through the appointment request form, call (314) 481-5000, or text (314) 886-5902. You can review the full range of pain treatments, read about the pain management doctors in St. Louis, or find both offices on the locations page.
Sources
- Schultz DM, Orhurhu V, Khan F, Hagedorn JM, Abd-Elsayed A. “Patient Satisfaction Following Intrathecal Targeted Drug Delivery for Benign Chronic Pain: Results of a Single-Center Survey Study.” Neuromodulation, 2020;23(7):1009–1017. 443 of 610 active patients responded. doi:10.1111/ner.13167
Dr. Gurpreet Singh Padda, MD, MBA, MHP
